Croda International PLC 2020 AR2
The report highlights Croda's performance and sustainability progress in 2020, during which the company launched its 2030 Commitment to be Climate, Land, and People Positive. Despite the challenges of the COVID-19 pandemic, Croda maintained business continuity, supported the Pfizer-BioNTech vaccine with critical lipid components, and completed the strategic acquisitions of Avanti Polar Lipids and Iberchem. Environmentally, the company achieved a 15.4% reduction in greenhouse gas emissions and a 33.9% reduction in waste-to-landfill since 2015, while increasing its bio-based organic raw material content to 67%.
Company: Croda International PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2020
Type: AR2
Pages: 176
Croda International PLC
The report highlights Croda's performance and sustainability progress in 2020, during which the company launched its 2030 Commitment to be Climate, Land, and People Positive. Despite the challenges of the COVID-19 pandemic, Croda maintained business continuity, supported the Pfizer-BioNTech vaccine with critical lipid components, and completed the strategic acquisitions of Avanti Polar Lipids and Iberchem. Environmentally, the company achieved a 15.4% reduction in greenhouse gas emissions and a 33.9% reduction in waste-to-landfill since 2015, while increasing its bio-based organic raw material content to 67%.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Women on Board
Women in Management
Net Zero Target
Employees